Clinical Study| Volume 12, ISSUE 4, P426-428, May 2005

Download started.


Mitochondrial respiratory chain dysfunction in various neuromuscular diseases


      The mitochondrial respiratory chain function and the occurrence of mitochondrial respiratory chain dysfunction were determined in various neuromuscular diseases. The mitochondrial complexes I–V and citrate synthase in the skeletal muscle taken from 75 orthopaedic surgical patients excluding neuromuscular diseases (control subjects) and 26 patients with various neuromuscular diseases (7 patients with Duchenne muscular dystrophy, 3 patients with spinal muscular atrophy, 6 patients with mitochondrial diseases, 7 patients with type II fibre atrophy and 3 patients with neuropathy) were assayed. Of 26 patients, results of analysis of 3 patients (1 Duchenne muscular dystrophy, 1 spinal muscular atrophy and 1 type II fibre atrophy) were excluded because the citrate synthase activities in their muscle homogenate were less than third percentile of the normal controls. As compared to the control subjects by using Student’s t-test, all studied groups of patients had significantly lower activities of more than one or two mitochondrial complexes (p < 0.05). However, a significantly higher activity of mitochondrial complex I was observed in patients with mitochondrial diseases (p < 0.05). These findings will require further study to elucidate the pathogenesis and role of secondary mitochondrial respiratory chain dysfunction in such neuromuscular diseases.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Clinical Neuroscience
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Morgan-Hughes J.A.
        Mitochondrial diseases.
        in: 2nd edition. Myology. Vol. 2. McGraw-Hill, Inc., New York1994: 1610-1660
        • Trounce I.
        • Byrne E.
        • Marzuki S.
        Decline in skeletal muscle mitochondrial respiratory chain function: possible factor in aging.
        Lancet. 1989; 1: 637-639
        • Mhiri C.
        • Baudrimont M.
        • Bonne G.
        • et al.
        Zidovudine myopathy: a distinctive disorder associated with mitochondrial dysfunction.
        Ann Neurol. 1991; 29: 606
        • Yamamoto M.
        • Koga Y.
        • Ohtaki E.
        • Nonaka I.
        Focal cytochrome C oxidase deficiency in various neuromuscular diseases.
        J Neurol Sci. 1989; 91: 207-213
        • Birch-Machin M.A.
        • Briggs H.L.
        • Saborido A.A.
        • Bindoff L.A.
        • Turnbull D.M.
        An evaluation of the measurement of the activities of complex I–IV in the respiratory chain of human skeletal muscle mitochondria.
        Biochem Med Met Biol. 1994; 51: 35-42
        • Zheng X.
        • Shoffner J.M.
        • Voljavec A.S.
        • Wallace D.C.
        Evaluation of procedures for assaying oxidative phosphorylation enzyme activities in mitochondrial myopathy muscle biopsies.
        Biochem Biophy Acta. 1990; 1019: 1-10
        • Rustin P.
        • Chretin D.
        • Bourgeron T.
        • Gerard B.
        • Rotig A.
        • Saudukray J.M.
        • et al.
        Biochemical and molecular investigations in respiratory chain deficiencies.
        Clin Chem Acta. 1994; 228: 35-51
        • Hatefi Y.
        Resolution of complex II and isolation of succinate dehydrogenase (EC
        Meth Enzymol. 1978; LIII: 27-34
        • Krahenbuhl S.
        • Talos C.
        • Wiesmann U.
        • Hoppel C.L.
        Development and evaluation of a spectrophotometric assay for complex III in isolated mitochondria, tissues and fibroblasts from rat and humans.
        Clin Chem Acta. 1994; 230: 177-187
        • Haas R.H.
        • Nasirian F.
        • Nakano K.
        • Ward D.
        • Pay M.
        • Hill R.
        • et al.
        Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson’s disease.
        Ann Neurol. 1995; 37: 714-722
        • Takemori S.
        • King T.E.
        Reconstitution of respiratory chain enzyme system XIII sequential fragmentation of succinate oxidase: preparation and properties of succinate-cytochrome C reductase and the cytochrome B-C1 particle.
        J Biol Chem. 1964; 239: 3546-3558
        • Byrne E.
        Biochemical defects in mitochondrial cytopathies: a new classification.
        Aust Paediatr J. 1988; 24: 58-61
        • Nordin R.A.
        • Johns D.R.
        Mitochondrial dysfunction and neuromuscular disease.
        Muscle Nerve. 2001; 24: 170-191